Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.
about
A selective screening program for the early detection of mucopolysaccharidosis: Results of the FIND project - a 2-year follow-up study.How close are we to therapies for Sanfilippo disease?Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.Gene therapy for Mucopolysaccharidoses.
P2860
Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Near-Complete Correction of Pr ...... IV rAAV9-hNAGLU Gene Delivery.
@en
type
label
Near-Complete Correction of Pr ...... IV rAAV9-hNAGLU Gene Delivery.
@en
prefLabel
Near-Complete Correction of Pr ...... IV rAAV9-hNAGLU Gene Delivery.
@en
P2093
P2860
P1433
P1476
Near-Complete Correction of Pr ...... IV rAAV9-hNAGLU Gene Delivery.
@en
P2093
Aaron S Meadows
Douglas M McCarty
Robert P Mohney
Tierra Ware
P2860
P304
P356
10.1016/J.YMTHE.2016.12.025
P577
2017-01-28T00:00:00Z